Palantir’s, Pre-Earnings

Palantir’s Pre-Earnings Slide Deepens as the Market Picks Sides Ahead of August 3

Published on 07/29/2026 at 13:03 | Redaktion boerse-global.de

Palantir shares drop 6% as Cleveland Research flags soft commercial spending, with Q2 earnings due Monday. Stock down 31% YTD, trading below key moving averages.

Palantir Stock Plunges 31% YTD Ahead of Q2 Earnings Amid Commercial Spending Concerns
Palantir’s Pre-Earnings Slide Deepens as the Market Picks Sides Ahead of August 3 Illustration mit AI erstellt übermittelt durch boerse-global.de

The selling in Palantir shares has taken on a life of its own, and it’s happening in plain sight. On Tuesday, the stock dropped 6.17 percent to close at €108.60, extending a year-to-date decline that now stands at roughly 31 percent. The move came without a confirmed catalyst from the company itself, but a brief note from Cleveland Research suggesting softness in commercial customer spending was enough to trigger the rout. Palantir has not addressed the claim.

What makes the sell-off notable is its timing. The second-quarter earnings report is scheduled for Monday, August 3, after the US market close. The current slide is unfolding in the final trading sessions before that release — a textbook case of the market pricing in uncertainty rather than reacting to confirmed bad news. The stock is now trading nearly 5 percent below its 50-day moving average and more than 17 percent below the 200-day average, confirming a clear medium-term downtrend.

The technical damage is substantial. Palantir hit an all-time high of €179.98 in November, then fell to a year-to-date low of €93.30 in late June — a decline of nearly 40 percent from peak to trough, with only a weak recovery since. The relative strength index sits at 45, indicating neither oversold conditions nor genuine upward momentum. With annualized volatility above 56 percent, investors should brace for sharp swings in either direction around the earnings report.

The Earnings Bar Is Set Exceptionally High

Wall Street expects Palantir to report revenue of $1.8 billion and earnings of $0.35 per share for the second quarter. That would represent year-over-year growth of 80 percent in revenue and a 169 percent jump in profit. The company’s own guidance calls for revenue between $1.797 billion and $1.801 billion, with adjusted operating income in the range of $1.063 billion to $1.067 billion.

Should investors sell immediately? Or is it worth buying Palantir?

Some analysts see room for an upside surprise. Oppenheimer’s Param Singh, who rates the stock “Outperform” with a $200 price target, expects revenue growth of roughly 85 percent — well above Palantir’s own forecast of about 79 percent — and anticipates a raised full-year outlook. For the commercial US business specifically, Singh projects growth of 135 percent in the second quarter, directly contradicting the bearish thesis that triggered the recent sell-off.

Yet the very optimism among analysts may be part of the problem. The consensus already embeds expectations for a beat-and-raise quarter. Palantir has a history of delivering those, but at the current valuation, anything short of a clear record quarter tends to be punished. That dynamic played out in May, when the stock fell despite solid numbers, simply because the guidance raise wasn’t dramatic enough.

The Valuation Conundrum

Despite the sharp decline, Palantir remains expensive relative to peers. The stock trades at a significant premium to established software and defense technology companies, a premium that rests on expectations of sustained exceptional growth. The average analyst price target stands at €160.19, implying upside of roughly 47.5 percent from current levels. That gap can be read two ways: either the market has already priced in considerable skepticism, or investors have simply lost patience with a growth story that has yet to deliver a clean beat-and-raise quarter in 2026.

The bear case centers on the sustainability of that growth. Skeptical analysts project annual expansion of 20 to 30 percent, a pace that would make the current valuation difficult to justify. Competition is also creeping into the narrative. Established defense contractors and newer technology providers are pushing more aggressively into the government data integration and analytics market, challenging Palantir’s historical dominance and raising questions about long-term pricing power. Whether or not that thesis proves correct, its mere circulation appears to be generating selling pressure.

Bulls Point to the Balance Sheet and Government Business

The bull case rests on more than just hope. Palantir holds $8.0 billion in cash and government securities with zero debt, giving it significant strategic flexibility regardless of near-term stock movements. The US government business remains the company’s largest growth driver, and Palantir recently raised its full-year 2026 revenue forecast to between $7.650 billion and $7.662 billion. The commercial US segment is expected to contribute at least $3.224 billion, representing growth of 120 percent or more.

Palantir at a turning point? This analysis reveals what investors need to know now.

Oppenheimer’s Singh sees the government business as the primary catalyst, and the company’s balance sheet provides a cushion that many high-growth tech peers lack. That combination — strong government demand and a fortress-like financial position — forms the foundation of the bull thesis, even as the stock struggles to find its footing.

What August 3 Will Decide

The earnings report on Monday will serve as a critical inflection point. If Palantir raises its guidance again and the commercial US business continues growing at the roughly 133 percent pace of the prior period, the stock could begin a gradual recovery toward the analyst consensus of €160.19. If the company merely confirms its existing outlook without a meaningful upgrade, the shares may test new lows below the current 52-week trough of €93.30. Several observers consider that scenario likely given the elevated expectations already priced in.

Between now and the release, the stock is likely to remain volatile. Insider sales, unresolved questions around Palantir’s partnership with the UK’s National Health Service, and a broader weakness in expensive AI software names all add to the uncertainty. For investors, the next few days are less about parsing quarterly numbers and more about whether the growth story can still command the premium the market has assigned to it. The answer will come on August 3.

Ad

Palantir Stock: New Analysis - 29 July

Fresh Palantir information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Palantir analysis...

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | US69608A1088 | PALANTIR’S | boerse | 69896010 |